1. bookVolume 24 (2018): Issue 1 (February 2018)
Journal Details
License
Format
Journal
First Published
16 Feb 2013
Publication timeframe
4 times per year
Languages
English
access type Open Access

Inflammatory Bowel Diseases: Focus on Therapy

Published Online: 24 Apr 2018
Page range: 9 - 14
Journal Details
License
Format
Journal
First Published
16 Feb 2013
Publication timeframe
4 times per year
Languages
English

INTRODUCTION: Medical management of Inflammatory Bowel Diseases is complex and tailored to disease activity. The primary goal is the induction of remission and maintenance of remission with longterm prevention of disease progression. AIM: to describe current drug treatment practices in Inflammatory Bowel Diseases in Dobrogea.

Keywords

1. Gomollon F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis. 2017;11(1):3-25.Search in Google Scholar

2. Krstic M, Tarabar D, Bojic D, Nagorni A, Hadnadjev L, Dugalic P, et al. P421 Epidemiological study of occurrence, clinical course and treatment options of IBD in Serbia. Results of ESCApe study. Journal of Crohn’s and Colitis. 2012;6:S177.Search in Google Scholar

3. Kurti Z, Vegh Z, Golovics PA, Fadgyas-Freyler P, Gecse KB, Gonczi L, et al. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database. Dig Liver Dis. 2016;48(11):1302-7.Search in Google Scholar

4. Williams C, Panaccione R, Ghosh S, Rioux K. Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. Therapeutic advances in gastroenterology. 2011;4(4):237-48.Search in Google Scholar

5. Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel J-F, Allez M, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. Journal of Crohn’s and Colitis. 2012;6(10):991-1030.Search in Google Scholar

6. Rencz F, Pentek M, Bortlik M, Zagorowicz E, Hlavaty T, Sliwczynski A, et al. Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe. World J Gastroenterol. 2015;21(6):1728-37.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo